Topic: Excessive pricing

Israel seeks first excessive pricing penalty

Israel’s Competition Authority plans to fine a pharmaceutical company €2.3 million for charging excessive prices for a life-saving genetic disorder medication, which would mark the first time the enforcer has issued sanctions for such an infringement.

24 November 2021

China punishes pharmaceutical supplier for abuse of dominance

China’s competition watchdog has ordered one of the country’s largest suppliers of active pharmaceutical ingredients to pay over €1.4 million for imposing excessive prices on drug manufacturers from 2014 to 2017.

02 November 2021

Price comparison website faces UK class action over MFN clauses

Hausfeld has filed an opt-out class action claim against Compare The Market seeking over €440 million in damages based on an infringement decision by the UK’s antitrust enforcer, although the lawsuit may be dropped if the price comparison website is successful in its appeal that began today.

01 November 2021

CMA launches market investigation into Motorola’s Airwave network

The UK’s Competition and Markets Authority has launched a market investigation into Motorola’s Airwave network – the mobile radio network used by all emergency services in Great Britain – after a public consultation reinforced the agency’s concerns that the company may be earning excess profits.

25 October 2021

UK tribunal certifies first excessive pricing class action

The UK's Competition Appeal Tribunal has certified its second-ever class action, allowing a claim to proceed that seeks €469 million in damages from BT for allegedly overcharging 2.3 million landline service customers.

27 September 2021

India hits beer cartel with major fines

The Competition Commission of India has fined United Breweries, Carlsberg and eight of their executives a total of 9 billion rupees (€104 million) for price-fixing, collectively restricting supplies and dividing the country’s beer market.

24 September 2021

Mexico hits drug distributors with highest possible fine

Mexico’s competition enforcer has fined five drug distributors, an industry association and 21 executives the highest possible combined sanction of €38.5 million, while also disqualifying senior company employees for the first time in its history.

17 August 2021

CMA to probe “exploitative” coronavirus testing kit prices

The UK’s antitrust watchdog has agreed to advise the government on whether travellers are being charged excessive prices for covid-19 tests after the health secretary asked it to conduct a “rapid high-level review”.

09 August 2021

CMA reaccuses Pfizer and Flynn of excessive pricing

The UK’s Competition and Markets Authority has accused Pfizer and Flynn Pharma of charging unfairly high prices for an anti-epilepsy medication, 17 months after an appellate court ordered the agency to redo parts of its initial probe into the drugmakers.

05 August 2021

CMA doles out £100 million in fines for excessive pricing of thyroid drug

The UK’s Competition and Markets Authority has hit Advanz Pharma and its two former owners with more than £100 million in fines for overcharging the country’s national health service for thyroid medication liothyronine over an eight-year period.

29 July 2021

Get unlimited access to all Global Competition Review content